MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

ESMO Open - Tập 5 - Trang e000937 - 2020
Annalisa Petrelli1, Sara Erika Bellomo2, Ivana Sarotto3, Franziska Kubatzki4, Paola Sgandurra4, Furio Maggiorotto4, Maria Rosaria Di Virgilio5, Riccardo Ponzone4, Elena Geuna6, Danilo Galizia6, Anna Maria Nuzzo7, Enzo Medico2,8, Umberto Miglio3, Enrico Berrino3,9, Tiziana Venesio3, Salvatore Ribisi1, Paolo Provero10,11, Anna Sapino3,9, Silvia Giordano1,2, Filippo Montemurro6
1Cancer Molecular Biology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
2Department of Oncology, University of Turin, Torino, Italy
3Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
4Gynaecological Oncology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
5Radiology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
6Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
7Clinical Research Office, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
8Oncogenomics Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
9Department of Medical Sciences, University of Turin, Torino, Italy
10Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy
11Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milano, Italy

Tài liệu tham khảo

Siegel Burstein Perou Sorlie Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Lin Bottani Di Cosimo Di Cosimo Zou Li Wang Zhang Jamali Motawi Doghman Shi Catto Drayton Ross-Innes Fu Tomlinson Knowlden Bhola Miller deGraffenried Petrelli McShane Viré Lánczky Curtis Dowsett Cheang Qureshi
Thông tin
Thông tin xuất bản

ESMO Open

Tập 5

e000937

Thông tin tác giả